Seller record · plushcare.com

PlushCare

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S3, pharmacy identification: Eight pages were read, covering the terms, privacy, health-privacy notice, contact and treatment surfaces, and each refers to the pharmacy of the patient's choice or an unnamed compounding partner. 1 more criterion also fails; see the table below.

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A primary-care telehealth service that prescribes brand and compounded GLP-1 drugs among many other treatments. It routes prescriptions to a pharmacy the patient chooses rather than to one it names.

Operating entity PlushCare of California, Inc., P.C.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	plushcare.com/about
S2	Prescription gating	PASS	my.plushcare.com/survey/weight-loss/onboarding
S3	Pharmacy identification	FAIL	plushcare.com/wegovy-semaglutide-prescription
S4	Compounding disclosure	PASS	plushcare.com/wegovy-semaglutide-prescription
S5	Analytical documentation	FAIL	plushcare.com/semaglutide-prescription
S6	Business address	PASS	plushcare.com/hipaa-notice-of-privacy-practices
S7	Price disclosure	PASS	plushcare.com/semaglutide-prescription
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSThe about page states that physicians are board certified and selected from fifty United States medical institutions, and it names no individual prescriber.Source: plushcare.com/about.

S2PASSThe order path was walked to a weight-loss onboarding survey that opens with medical questions, reached before any payment field.Source: my.plushcare.com/survey/weight-loss/onboarding.

S3FAILEight pages were read, covering the terms, privacy, health-privacy notice, contact and treatment surfaces, and each refers to the pharmacy of the patient's choice or an unnamed compounding partner.Source: plushcare.com/wegovy-semaglutide-prescription.

S4PASSThe Wegovy page states that compounded semaglutide, like all compounded drugs, is not Food and Drug Administration approved.Source: plushcare.com/wegovy-semaglutide-prescription.

S5FAILEight pages were searched for thirteen certificate and testing terms, and none returns a certificate, a lot number or a purity figure.Source: plushcare.com/semaglutide-prescription.

S6PASSThe health-privacy notice prints a street address with a suite number on Market Street in San Francisco, California.Source: plushcare.com/hipaa-notice-of-privacy-practices.

S7PASSThe semaglutide page prints 129 dollars for a visit without insurance, and the homepage repeats that figure as the appointment fee.Source: plushcare.com/semaglutide-prescription.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: brand GLP-1 prescriptions, compounded semaglutide, primary-care prescriptions, mental health prescriptions.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.